State Key Laboratory of Reproductive Medicine, Clinical Center of Reproductive Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Front Endocrinol (Lausanne). 2022 May 23;13:851213. doi: 10.3389/fendo.2022.851213. eCollection 2022.
To study the influence of the previous cesarean section on the pregnancy outcomes and perinatal outcomes in single embryo transfer (SET) cycles in an fertilization/intracytoplasmic sperm injection-embryo transfer (IVF/ICSI-ET) setting compared to those with previous vaginal delivery (VD). In addition, the association between fertility outcomes and different cesarean scar defect (CSD) sizes was studied.
This was a retrospective cohort study conducted in the Reproductive Center of the First Affiliated Hospital of Nanjing Medical University. A total of 4,879 patients with previous delivery history undergoing SET were included between January 2015 and April 2019. Patients were divided into the VD group and cesarean delivery (CD) group according to different modes of previous delivery. The primary outcome was live birth rate. The pregnancy outcomes of CD were analyzed as a subgroup and the relationship between pregnancy outcomes as well as the different sizes of CSD were explored by logistic regression analysis.
There were no significant differences in live birth rate, clinical pregnancy rate, and miscarriage rate between the CD group and VD group. The incidence rates of pregnancy complications such as pregnancy hypertension, gestational diabetes mellitus, placenta abnormalities, premature rupture of membrane, and postpartum hemorrhage were similar in the two groups. Live birth rate was significantly lower in the CSD group (23.77% vs 37.01%, aOR: 0.609, 95% CI: 0.476-0.778) comparing to patients without CSD. There were also significant differences in clinical pregnancy rate (37.52% vs 47.64%, aOR: 0.779, 95%CI: 0.623-0.973) and miscarriage rate (34.55% vs 20.59%, aOR: 1.407, 95%CI:1.03-1.923). Large size CSD significantly decreased live birth rate (13.33% vs 26.29%, aOR: 0.422, 95%CI: 0.197-0.902) and clinical pregnancy rate (25.33% vs 40.09%, aOR: 0.503, 95%CI: 0.272-0.930) compared with small size CSD.
For women with previous cesarean sections, the pregnancy outcomes were similar to those with previous VD without increased perinatal complications following SET. The presence of CSD was associated with a marked reduction in live birth rate, especially in patients with large size CSD.
在体外受精/卵胞浆内单精子注射-胚胎移植(IVF/ICSI-ET)治疗中,比较既往剖宫产与既往阴道分娩对单胚胎移植(SET)周期妊娠结局和围产结局的影响,并研究不同大小的剖宫产瘢痕缺陷(CSD)与生育结局的关系。
这是一项在南京医科大学第一附属医院生殖中心进行的回顾性队列研究。纳入 2015 年 1 月至 2019 年 4 月期间有既往分娩史并接受 SET 的 4879 例患者。根据既往分娩方式的不同,将患者分为阴道分娩(VD)组和剖宫产(CD)组。主要结局为活产率。分析 CD 组的妊娠结局,并通过 logistic 回归分析探讨妊娠结局与不同 CSD 大小的关系。
CD 组与 VD 组的活产率、临床妊娠率和流产率无显著差异。两组妊娠高血压、妊娠期糖尿病、胎盘异常、胎膜早破和产后出血等妊娠并发症的发生率相似。与无 CSD 的患者相比,CSD 组的活产率显著降低(23.77% vs 37.01%,aOR:0.609,95%CI:0.476-0.778)。CSD 组的临床妊娠率(37.52% vs 47.64%,aOR:0.779,95%CI:0.623-0.973)和流产率(34.55% vs 20.59%,aOR:1.407,95%CI:1.03-1.923)也有显著差异。较大的 CSD 显著降低了活产率(13.33% vs 26.29%,aOR:0.422,95%CI:0.197-0.902)和临床妊娠率(25.33% vs 40.09%,aOR:0.503,95%CI:0.272-0.930)。
对于有既往剖宫产史的妇女,在 SET 后,其妊娠结局与既往 VD 相似,围生期并发症无增加。CSD 的存在与活产率显著降低相关,尤其是在较大的 CSD 患者中。